News
Program
9h: introduction of the Day
9h15: Biological Session
- Mechanistic Insights in Stromal Cell Therapy for Musculoskeletal Diseases ̶ Dr Ana Ivanovska, University of Galway, Ireland.
- Development of a panel of functional tests of mesenchymal stem cells with High Content Screening imaging ̶ Dr Margot Tertrais, Université de Toulouse, France.
- Micro-encapsulation of mesenchymal stem cells in alginate hydrogels for osteoarthritis ̶ Mathilde Ambrosino, Université de Nantes, France.
10h00: Alloreactivity, immune response Session
- Immunomonitoring of patients from RESPINE clinical trial ̶ Dr Pascale LOUIS-PLENCE, IRMB Montpellier & Dr Joelle DULONG, SITI Lab, Rennes.
- Metabolic reprogramming of mesenchymal stromal cells controls their immunoregulatory functions ̶ Dr Farida DJOUAD, IRMB, Montpellier .
Coffee break
11h: MSV Bioproduction Session
- Design and improvement of conditions for cell production, cryopreservation, revitalization and transport ̶ Pr Ana Sanchez, CITOSPIN & Pr Javier García-Sancho University of Valladolid (UVa), Spain.
- Design of a panel for Phenotypic identification of MSV2 and purification follow-up ̶ Dr Mercedes Alberca, Citospin, Spain.
11h45: IPSPINE Project ̶
Pr Marianna Tryfonidou, Utrecht University, The Netherlands.
Lunch
14h15: RESPINE Clinical trial Session
- Unconventional analysis of clinical data in RESPINE and other previous clinical assays ̶ Dr Margarita Gonzalez Vallinas, CITOSPIN Quality Director and UVa Assistant Professor.
- RESPINE Project ̶ Pr Christian Jorgensen, Centre Hospitalier Universitaire de Montpellier, France.
15h: MRI Session
- Spine MRI as predictor of clinical response ̶ Pr Gianluca Vadalà, Fondazione Policlinico Universitario Campus Bio Medico, Italy.
- Imaging result in the RESPINE study ̶ Pr Robet SOLER, Institut De Terapia Regenerativa Tisular, Spain.
15h45: Other Regenerative Medecine Session
- ATMP quality controls: objectives and issues related to bio manufacturing and market access ̶ Pr Louis Casteilla, Université de Toulouse, France.
- iPS as cell therapy: where do we stand ̶ Pr John Devos, Centre Hospitalier Universitaire de Montpellier, France.
- Extracellular vesicles as biological vectors of information and a novel nanomedicine approach for diseases associated with obesity ̶ Dr Ramaroson Andriantsitohaina, CNRS, France.
Conférences
Satellite Symposium at the Biospine 7th International Congress on Biotechnologies for Spinal Surgery, Rome, Italy, 3-5 April 2019.
Programme of the RESPINE Satellite Symposium, 5 April 2019.